Add to ORKGImpact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort stud
BACKGROUND: Valid estimation of the incidence and risk factors for venous thromboembolism (VTE) amon...
Background The incidence of venous thromboembolism (VTE) is 1-2/1000 individuals. Patients with canc...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...
OBJECTIVES: To assess the interaction between comorbidity and breast cancer (BC) on the rate of veno...
Objectives: To assess the interaction between comorbidity and breast cancer (BC) on the rate of veno...
BACKGROUND: Venous thromboembolism (VTE) is a serious complication of cancer. It is unknown whether ...
Background: Although venous thromboembolism (VTE) is a known common complication in cancer patients,...
BACKGROUND: Although venous thromboembolism (VTE) is a known common complication in cancer patients,...
Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been...
AbstractPurposeVenous thromboembolism (VTE) is associated with renal cell carcinoma (RCC), but data ...
Background: Breast cancer patients are at an increased risk of venous thromboembolism (VTE). However...
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade...
Patients with breast cancer are at increased risk of venous thromboembolism (VTE), particularly in t...
Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been...
BACKGROUND: Venous thromboembolism (VTE) is a serious complication of cancer and its treatme...
BACKGROUND: Valid estimation of the incidence and risk factors for venous thromboembolism (VTE) amon...
Background The incidence of venous thromboembolism (VTE) is 1-2/1000 individuals. Patients with canc...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...
OBJECTIVES: To assess the interaction between comorbidity and breast cancer (BC) on the rate of veno...
Objectives: To assess the interaction between comorbidity and breast cancer (BC) on the rate of veno...
BACKGROUND: Venous thromboembolism (VTE) is a serious complication of cancer. It is unknown whether ...
Background: Although venous thromboembolism (VTE) is a known common complication in cancer patients,...
BACKGROUND: Although venous thromboembolism (VTE) is a known common complication in cancer patients,...
Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been...
AbstractPurposeVenous thromboembolism (VTE) is associated with renal cell carcinoma (RCC), but data ...
Background: Breast cancer patients are at an increased risk of venous thromboembolism (VTE). However...
The incidence of venous thromboembolism (VTE) in cancer patients may have changed in the past decade...
Patients with breast cancer are at increased risk of venous thromboembolism (VTE), particularly in t...
Survival of breast cancer patients with comorbidity, compared to those without comorbidity, has been...
BACKGROUND: Venous thromboembolism (VTE) is a serious complication of cancer and its treatme...
BACKGROUND: Valid estimation of the incidence and risk factors for venous thromboembolism (VTE) amon...
Background The incidence of venous thromboembolism (VTE) is 1-2/1000 individuals. Patients with canc...
Breast cancer patients are at increased risk of VTE, particularly in the peri-diagnosis period. Howe...